# clm_2FBA71C4F385

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 7,095,000,000 United States dollar  
valid_from: 2026-06-30  
valid_to: 2026-09-30  
published: 2026-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_9D57FD94603E  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 7,095,000,000 United States dollar", as of 2026-06-30 (until 2026-09-30). Claim clm_2FBA71C4F385, https://asof.is/claim/clm_2FBA71C4F385, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/0000059478-26-000081-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/0000059478-26-000081-index.htm (primary, SEC EDGAR 10-Q Q2 FY2026, published 2026-08-05)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 7,396,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_2FBA71C4F385](/claim/clm_2FBA71C4F385.md) | [clm_063460475B4C](/claim/clm_063460475B4C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.